Skip to main content
3-D-Printing Tumors for Medical Research
Study in a Sentence: A Swedish biotechnology company called Cellink is branching into the field of 3-D-bioprinting of human tumors for biomedical research by collaborating with French biotechnology company CTI Biotech. CTI Biotech specializes in producing tissues for cancer treatment research. Cellink produces a bioink that allows human cells to survive. The companies can combine their products to create replicas of human tumors specific to each patient.
Healthy for Humans: The bioprinted human tumors can be used to identify drug targets, screen for drug candidates, and make personalized medicine a reality for cancer patients.
Redefining Research: This industry partnership promises to accelerate cancer research by providing abundant human-relevant cancer tissues and models to replace animals for understanding cancer disease processes and testing candidate treatments.
References
- Tom Turula. Sweden’s hottest biotech startup is now 3D printing tumors to help cure cancer. Business Insider Nordic. Jan 9, 2018. Available at: https://nordic.businessinsider.com/swedens-hottest-biotech-company-cellink-is-launching-a-revolutionary-treatment-for-cancer--/
